Tamoxifen citrate loaded ethosomes for transdermal drug delivery system: Preparation and characterization

Current Drug Delivery

Volumn 10, Issue 4, 2013, Pages 466-476

  Sarwa, Khomendra Kumar ^a   Suresh, Preeti K ^b   Debnath, Manabendra ^c   Ahmad, Mohammad Zaki ^d  

^a DIBRUGARH UNIVERSITY   (India)

^b PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

^c Department of Human Physiology   (India)

^d NAJRAN UNIVERSITY   (Saudi Arabia)

Author keywords

Ethosomes; Liposomes; Skin; Tamoxifen citrate; Transdermal

Indexed keywords

DRUG CARRIER; ETHOSOME; LIPOSOME; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG;

ARTICLE; CADAVER; CALORIMETRY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; ENZYMATIC DEGRADATION; EPIRETINAL MEMBRANE; HUMAN; HUMAN TISSUE; PARTICLE SIZE; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; ZETA POTENTIAL;

EID: 84882767404     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811310040011     Document Type: Article

References (34)

1. Braun-Falco, O.; Kortung, H.C.; Maibach, H.I. Grieswithbach Conference: Liposome Dermatics, Springer-Verlag, Berlin, Heidelberg, 1992.
2. Schreier, H. Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery, J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control Release, 1994, 30,1-15.
3. Lasch, J.; Laub, R.; Wohlrab, W. How deep do intact liposomes penetrate into human skin? J. Control Release, 1991, 18, 55-58.
4. Cevc, G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration and trans-dermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 1996, 13, 257-388.
5. Touitou, E.; Dayan, N.; Bergelson, L.; Godin, B.; Eliaz, M. Etho-somes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control Release, 2000, 65, 403-418.
6. Dayan, N., Touitou, E. Carrier for skin delivery of trihexyphenidyl HCl: Ethosomes vs liposomes. Biomaterials, 2000, 21, 1879-1885.
7. Lodzki, M.; Godin, B.; Rakou, L.; Mechoulam, R.; Gallily, R.; Touitou, E. Cannabidol transdermal delivery and anti-inflammatory effect in a marine model. J. Control Release, 2003, 93, 379-389.
8. Godin, B.; Touitou, E.; Rubinstein, E.; Athamna, A.; Athamna, M.A. New approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J. Antimicrob. Chemother., 2005, 55, 989-994.
9. Esposito, E.; Menegatti, E.; Cortesi, R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. Int. J. Cosmetic Sci., 2004, 26, 270.
10. Elsayed, M.M.; Abdallah, O.Y.; Naggar, V.F.; Khalafallah, N.M. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Int. J. Pharm., 2006, 30, 60-67.
11. Jain, S.; Umamaheshwari, R.B.; Bhadra, D.; Jain, N.K. Ethosomes-A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Indian J. Pharm. Sci., 2004, 66, 72-81.
12. Paolino, D.; Lucania, G.; Mardente, D.; Alhaique, F.; Fresta, M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control Release, 2005, 106, 99-110.
13. Dubey, V.; Mishra, D.; Jain, N.K. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced trans-dermal delivery. Eur. J. Pharm. Biopharm., 2007a, 67, 398-405.
14. Dubey, V.; Mishra, D.; Dutta, T.; Nahar, M.; Saraf, D.K.; Jain, N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control Release, 2007b, 123, 148-154.
15. Fang, Y.P.; Tsai, Y.H.; Wu, P.C.; Huanga, Y.B. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int. J. Pharm., 2008, 356, 144-152.
16. Mishra, D.; Mishra, P.K.; Dabadghao, S.; Dubey, V.; Nahar, M.; Jain, N.K. Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomedicine: Nanotechnology, Bi-ol. Med., 2010, 6, 110-118.
17. Clarke, R.; Liu, M.C.; Bouker, K.B. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Onco-gene, 2003, 22, 7316-7339.
18. Memisoglu-Bilensoya, E.; Vurala, I.; Bochotb, A.; Renoirb, J.M.; Ducheneb, D.; Hincal, A.A. Tamoxifen citrate loaded amphiphilic h-cyclodextrin nanoparticles. J. Control Release, 2005, 104, 489-496.
19. Criscitiello, C.; Fumagalli, D.; Saini, K.S.; Loi, S. Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection. Onco. Targets Ther., 2010, 4, 1-11.
20. Jordan, V.C.; Tamoxifen: a most unlikely pioneering medicine. Nat. Rev. Drug Discov., 2003, 2, 205-213.
21. Gragnani, A.; Warde, M.; Furtado, F.; Ferreira, M. Topical ta-moxifen therapy in hypertrophic scars or keloids in burns. Arch. Dermatol. Res., 2010, 302, 1-4.
22. Shao, M.; Sun, S.; Li, M.; Li, B.; Yu, H.; Shen, Z.; Ren, Y.; Hao, Z.; Chang, N.; Peng, H.; Yang, B. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers. J. Liposome Res., 2012, 22, 168-176.
23. DeLima, G.R.; Facina, G.; Shida, J.Y.; Chein, M.B.C.; Tanaka, P.; Dardes, R.C.; Jordan, V.C.; Gebrim, L.H. Effects of low dose ta-moxifen on normal breast tissue from premenopausal women. Eur. J. Cancer, 2003, 39, 891-898.
24. Gao, S.; Singh, J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control Release, 1998, 51, 193-199.
25. Daoud-Mahammed, S.; Couvreur, P.; Amiel, C.; Besnard, M.; Appel, M.; Gref, R. Original tamoxifen-loaded gels: an in situ self-assembling system for cancer treatment. Drug Deliv. Sci. Technol., 2004, 14, 51-55.
26. Hu, D.; Hughes, M.A.; Cherry, G.W.; Topical tamoxifen-a potential therapeutic regime in treating excessive dermal scarring. Br. J. Plast. Surg., 1998, 5, 462-469.
27. Lopez-Pinto, J.M.; Gonzalez, M.L.; Rabasco, A.M. Effect of cholesterol and ethanol on dermal delivery from DPPc liposomes. Int. J. Pharm., 2005, 298, 1-12.
28. DeMedina, P.; Favre, G.; Poirot, M. Multiple targeting by the anti-tumor drug tamoxifen: a structure-activity study. Curr. Med. Chem. Anti. Cance. Agents, 2004, 4, 491-508.
29. Bhatia, A.; Kumar, R.; Katare, O.P. Tamoxifen in topical liposomes: Development, characterization and In-Vitro evaluation. Int. J. Pharmacy Pharm. Sci., 2004, 7, 252-259.
30. Williams, A. Transdermal and topical drug delivery from theory to clinical practice. Pharmaceutical press: London, 2003.
31. Ainbinder, D.; Touitou, E. Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv., 2005, 12, 297-303.
32. Ingólfsson, H.I.; Andersen, O.S. Alcohol's effects on lipid bilayer properties. Biophys. J., 2011, 17, 847-855.
33. Honeywell-Nguyen, P.L.; DeGraaff, A.M.; Groenink, H.W.W.; Bouwstra, J.A. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Bio. Chem. Biophys. Acta., 2002 1573, 130-140.
34. Kuijk-Meuwissen, M.E.; Mougin, L.; Junginger, H.E.; Bouwstra, J.A. Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study. J. Control Release, 1998, 56, 189-196.